SLSN · Solesence, Inc. Common Stock

Solésence achieved record full-year 2025 revenue of $62.1 million, representing 19% growth over 2024, driven by the company effectively doubling its consumer product line in two years. However, profitability metrics showed mixed results: while Q4 2025 saw improved gross margin (27% vs. 22% in Q4 2024) and a return to net income of $0.2 million from a $0.6 million loss, full-year gross margin declined to 26% from 31% and net income decreased to $1.8 million from $4.2 million. Management attributed the strong momentum exiting 2025 to organizational changes and the launch of the Transform & Transcend strategic initiative in November 2025. This initiative focuses on four pillars: operational excellence through lean management, technology-driven market expansion, service model innovation to increase value chain share, and collaborative globalization through new geographic entries with brand partners. CEO Kevin Cureton stated the initiative positions the company to deliver sustainable, profitable growth above industry averages. Recent operational highlights include appointing Yoolie Park as VP of Brand Partnerships, acquiring 20 new brand partners in facial skincare and color cosmetics, and expanding patent protection through 16 U.S. and foreign patents across technology platforms. The balance sheet shows total assets of $50.1 million as of December 31, 2025, with stockholders' equity of $17.6 million and cash of $1.3 million. CFO Laura Riffner expressed confidence in the company's ability to deliver against full-year 2026 objectives.